| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001768635-22-000002 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | O'Brien Greene & Co. Inc | 1768635 | PLX PHARMA INC | COM | 72942A107 | 244 | 60340 | SH | SOLE | 60340 | 0 | 0 | May 19th, 2022 01:14AM | May 19th, 2022 01:14AM | PLx Pharma | ||||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001600136-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Clearline Capital LP | 1600136 | PLX PHARMA INC | COM | 72942A107 | 96 | 23844 | SH | SOLE | 23844 | 0 | 0 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | PLx Pharma | ||||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001580642-22-002777 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Creative Planning | 1540235 | PLX PHARMA INC | COM | 72942A107 | 101 | 25000 | SH | SOLE | 0 | 0 | 25000 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | PLx Pharma | ||||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001567619-22-010951 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Cubist Systematic Strategies, LLC | 1603465 | PLX PHARMA INC | COM | 72942A107 | 50 | 12270 | SH | DFND | 1 | 0 | 12270 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | PLx Pharma | |||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | PLX PHARMA INC | COM | 72942A107 | 1 | 245 | SH | DFND | 5 | 245 | 0 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | PLx Pharma | |||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | PLX PHARMA INC | COM | 72942A107 | 115 | 28457 | SH | DFND | 3 | 28457 | 0 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | PLx Pharma | |||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | PLX PHARMA INC | COM | 72942A107 | 4 | 1100 | SH | DFND | 01 | 1000 | 100 | 0 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | PLx Pharma | |||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | PLX PHARMA INC | COM | 72942A107 | 452 | 111800 | SH | Call | DFND | 2 | 0 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | PLx Pharma | ||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | PLX PHARMA INC | COM | 72942A107 | 324 | 80200 | SH | Put | DFND | 2 | 0 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | PLx Pharma | ||
| nasdaq:plxp | nasdaq:plxp Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | PLX PHARMA INC | COM | 72942A107 | 408 | 101050 | SH | DFND | 2 | 101050 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | PLx Pharma |